Investor Relations

Recent Event

Access to Giving Virtual Investor Conference

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company’s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to COVID testing, results are typically provided in under 24 hours. ProPhase Labs also has deep experience with OTC consumer healthcare products and dietary supplements.

Investor Contact Information

Company

ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530

Investor Relations

CORE IR
T: (516) 222-2560
InvestorRelations@ProPhaseLabs.com